It has been reported that direct injection of IL-1 into the rodent brain upregulates beta-APP, supporting the idea that overexpression of IL-1 in the brain could be a driving force in AD pathogenesis (Sheng et al., 1996). This evidence concerns the gene IL1B and Alzheimer disease.